Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Study of Panitumumab and Regorafenib in Advanced or Metastatic KRAS and NRAS Wild Type Colorectal Cancers

NCT02199223 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT02199223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02199223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Study of Panitumumab and Regorafenib in Advanced or Metastatic KRAS and NRAS Wild Type Colorectal Cancers
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2014
Completion date
May 31, 2016
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kras and nras wild-type colorectal cancer